Yale Study Explores Ketones as a Strategy Against Hypoglycemia in Type 1 Diabetes
Insulin is a cornerstone of treatment for patients with type 1 diabetes, essential for lowering blood glucose levels. However, if insulin doses are not appropriately matched to the body’s needs, glucose levels can fall too low, resulting in hypoglycemia, a common and potentially dangerous complication of treatment. Hypoglycemia can impair thinking and cause symptoms ranging from dizziness and confusion to loss of consciousness. New research from Yale, published in the journal Diabetes, identifies a potential new strategy for protecting the brain from the cognitive effects of hypoglycemia in people with type 1 diabetes. The brain relies heavily on glucose as its primary source of fuel, explains Dr. Raimund Herzog, an associate professor of medicine specializing in endocrinology and metabolism, and the senior author of the study. "When glucose falls below a certain threshold, the neurons in the brain stop working properly," he notes. The goal of all of the studies conducted by Herzog and his team is to help people achieve better glucose control without the associated risk of hypoglycemia. "The easiest answer would be to take less insulin, but we know that higher glucose over the long term causes complications," Herzog adds. "The challenge is balancing good glucose control with the risk of hypoglycemia." The researchers investigated whether ketones, molecules that the body can use as an alternative source of energy, could protect the brain from the cognitive effects of low blood sugar. Specifically, they focused on a ketone called beta-hydroxybutyrate. Although ketones can often raise alarm for patients with type 1 diabetes due to their association with diabetic ketoacidosis, Herzog and his team found benefits of ketones when explored in a different metabolic context. Participants in the study continued to receive insulin treatment while dietary supplementation was used to modestly increase ketone levels, providing an additional source of fuel for the brain during episodes of low glucose. The study revealed that participants who received dietary supplementation to elevate their ketone levels performed better on tests of working memory during hypoglycemia compared to those who followed a standard diet. This suggests that increasing ketone availability may help preserve cognitive function when blood glucose is low. The researchers believe this effect may be related to how the brain adapts to repeated episodes of low blood sugar. Previous studies have shown that recurrent hypoglycemia enhances the brain’s ability to transport alternative fuels, including ketones, across the blood-brain barrier. The findings indicate that dietary supplementation could leverage this adaptation, providing the brain with an alternative energy source when glucose is scarce. Herzog hopes these findings could eventually offer an additional layer of protection for patients who experience recurrent hypoglycemia, especially those without access to continuous glucose monitoring technologies. "Continuous glucose sensors and modern insulin pumps have made hypoglycemia much less frequent, but not everyone has access to that technology," Herzog states. "Globally, many patients still rely on insulin injections and finger sticks to measure their glucose, so hypoglycemia remains a significant risk." Herzog emphasized the collaborative nature of the research, which combined expertise in endocrinology, neuroscience, and brain imaging through established partnerships with Yale’s Magnetic Resonance Research Center. He believes this multidisciplinary approach will continue to drive advances in diabetes research. "The goal of all of our studies is to help people achieve better glucose control without the associated hypoglycemia," says Herzog. "We’re dedicated to finding a safe way for people to maintain that balance." The research was supported by JDRF and the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, among other funding sources.




